✦ LIBER ✦

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

✍ Scribed by Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Korn; Elizabeth Dito; Brian Schillinger; Janet Scott; Jimmy Hwang; Margaret A. Tempero

Publisher: Springer
Year: 2010
Tongue: English
Weight: 266 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1257-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of S-1 in gemcitabine-r

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer

✍ Chigusa Morizane; Takuji Okusaka; Junji Furuse; Hiroshi Ishii; Hideki Ueno; Masa 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

A phase II study of capecitabine plus ge

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

✍ Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

A phase I/II study of gemcitabine-based

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

✍ Masashi Kanai; Kenichi Yoshimura; Masanori Asada; Atsushi Imaizumi; Chihiro Suzu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 263 KB

Phase II study of a fixed dose-rate infu

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

✍ J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Ini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 287 KB

Docetaxel plus gemcitabine in combinatio

Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study

✍ N. Xenidis; L. Chelis; K. Amarantidis; E. Chamalidou; P. Dimopoulos; N. Courcout 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB